House of Commons Health and Social Care Committee

House of Commons Health and Social Care Committee is a select committee of the House of Commons charged with oversight of health and social care matters in the United Kingdom. It scrutinises the policies, administration and expenditure of the Department of Health and Social Care, examines public bodies such as the National Health Service (England), and conducts inquiries involving stakeholders including professional regulators like the General Medical Council, charities such as NHS Charities Together, and academic institutions like the London School of Hygiene & Tropical Medicine. The committee links parliamentary scrutiny to national debates seen in venues like Downing Street and statements by figures such as the Prime Minister of the United Kingdom, the Secretary of State for Health and Social Care, and chairs of devolved bodies including the Scottish Government, the Welsh Government, and the Northern Ireland Executive.

History

The committee traces institutional roots to post-war parliamentary reforms reflected in the evolution of select committees after reports by the Committee on Privileges and the reforms associated with the 1979 United Kingdom general election. Its predecessor structures responded to policy shifts initiated under cabinets led by leaders such as Margaret Thatcher and Tony Blair, and to legislative milestones including the National Health Service and Community Care Act 1990 and the Health and Social Care Act 2012. High-profile episodes that shaped its remit include inquiries connected to crises referenced in reports by the Public Accounts Committee and investigations following events involving providers like Mid Staffordshire NHS Foundation Trust. The committee’s work produced cross-party collaborations with MPs from constituencies represented in debates in the House of Lords and has interacted with judicial reviews brought before the Supreme Court of the United Kingdom.

Remit and Powers

The committee’s statutory remit encompasses examination of expenditure, administration and policy of the Department of Health and Social Care and associated bodies such as NHS England, the Care Quality Commission, and arms-length bodies including NHS Improvement and Health Education England. It exercises powers derived from standing orders of the House of Commons to summon witnesses and require documents from entities including private providers like Bupa, pharmaceutical firms such as GlaxoSmithKline, and research funders like the Wellcome Trust. The committee produces reports which can prompt ministerial statements by holders of the Secretary of State for Health and Social Care portfolio and influence secondary legislation subject to scrutiny in the House of Commons Chamber. It also liaises with devolved health committees such as the Scottish Parliament Health, Social Care and Sport Committee and the Senedd Health Committee to address cross-border issues exemplified by responses to pandemics led by agencies like Public Health England and the World Health Organization.

Membership and Organisation

Membership comprises backbench MPs nominated by the Committee of Selection and elected under processes overseen by the House of Commons Commission, with chairs elected by the whole House as established after reforms linked to the 2009 expenses scandal. Members represent constituencies including urban and rural areas such as Manchester, Bristol, and Norfolk, and often include MPs with professional backgrounds in medicine, social care or law, similar to notable parliamentarians who have served on select committees like the Treasury Select Committee or the Public Accounts Committee. The committee staff includes clerks drawn from the House of Commons Library and specialist advisers appointed for inquiries, and it holds meetings in rooms such as Committee Room 14 and holds evidence sessions on the floor of the Palace of Westminster alongside procedures set by the Speaker of the House of Commons.

Inquiries and Reports

The committee conducts thematic inquiries into topics including mental health provision, social care funding, primary care capacity, and responses to public health emergencies such as the COVID-19 pandemic. It summons witnesses from organisations including Royal College of Nursing, British Medical Association, pharmaceutical manufacturers like Pfizer, and research institutions such as University College London. Reports often make recommendations influencing legislation debated in sessions involving the Secretary of State for Health and Social Care and can trigger interventions by watchdogs like the National Audit Office. Notable inquiries have addressed scandals involving providers like Bristol Royal Infirmary and systemic reviews that intersect with charity sector actors including Age UK and Carers UK.

Impact and Criticism

The committee has shaped policy through high-profile reports that prompted changes in practice by bodies such as NHS England and regulatory action by the Care Quality Commission, and has influenced public debate via media outlets like the BBC and The Guardian. It has been credited with increasing transparency and accountability after events similar to the Mid Staffordshire inquiry, yet critics argue its influence is constrained by ministerial resistance and limitations inherent in committee recommendations noted in analyses by think tanks such as the Institute for Government and the King's Fund. Debates around resource allocation have seen tensions with Treasury policy set by the Chancellor of the Exchequer and have involved external stakeholders including trade unions like Unison and patient groups such as Healthwatch England. Its effectiveness continues to be assessed amid ongoing reforms in health systems led by actors including NHS Providers and intergovernmental negotiations with devolved administrations.

Category:Select Committees of the British House of Commons